RAPP logo

RAPP
Rapport Therapeutics Inc

381
Mkt Cap
$1.8B
Volume
438,121.00
52W High
$42.27
52W Low
$7.73
PE Ratio
-15.25
RAPP Fundamentals
Price
$39.71
Prev Close
$37.72
Open
$38.35
50D MA
$34.09
Beta
1.46
Avg. Volume
338,466.98
EPS (Annual)
-$2.86
P/B
4.03
Rev/Employee
$0.00
$702.11
Loading...
Loading...
News
all
press releases
Rapport Therapeutics, Inc. (RAPP) Reports Q1 Loss
Rapport Therapeutics, Inc. (RAPP) delivered earnings and revenue surprises of +24.66% and 0.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
More News
News Placeholder
Rapport Therapeutics (RAPP) Expected to Announce Quarterly Earnings on Thursday
Rapport Therapeutics (NASDAQ:RAPP) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at...
News Placeholder
Rapport Therapeutics, Inc. (NASDAQ:RAPP) Receives Consensus Rating of "Buy" from Brokerages
Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) has been assigned a consensus rating of "Buy" from the ten brokerages that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, seven have issued a buy rating and two have issued a s...
News Placeholder
Rapport Insider Sells $17.2 Million as Stock Surges 230% in a Year and Phase 3 Trials Near
Key PointsA major owner of Rapport Therapeutics reported selling 426,005 shares for a total value of approximately $17.18 million on April 17, 2026...
News Placeholder
BTIG Research Reaffirms "Buy" Rating for Rapport Therapeutics (NASDAQ:RAPP)
BTIG Research restated a "buy" rating and issued a $53.00 target price on shares of Rapport Therapeutics in a research note on Wednesday...
News Placeholder
Insider Selling: Rapport Therapeutics (NASDAQ:RAPP) Insider Sells 20,225 Shares of Stock
Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) insider Krishnaswamy Yeleswaram sold 20,225 shares of Rapport Therapeutics stock in a transaction dated Friday, April 17th. The shares were sold at an average price of $39.99, for a total value of $808,797.75. Following the transaction, the...
News Placeholder
Insider Selling: Rapport Therapeutics (NASDAQ:RAPP) Major Shareholder Sells 426,005 Shares of Stock
Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) major shareholder Rock Ventures L.P. Third sold 426,005 shares of Rapport Therapeutics stock in a transaction dated Friday, April 17th. The...
News Placeholder
Krishnaswamy Yeleswaram Sells 20,225 Shares of Rapport Therapeutics (NASDAQ:RAPP) Stock
Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) insider Krishnaswamy Yeleswaram sold 20,225 shares of the company's stock in a transaction on Friday, April 17th. The stock was sold at an average price of $39.99, for a total transaction of $808,797.75. Following the completion of the...
News Placeholder
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 4.2% - Here's What Happened
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 4.2% - Time to Sell...
News Placeholder
Rapport Therapeutics (NASDAQ:RAPP) Sees Unusually-High Trading Volume - Still a Buy?
Rapport Therapeutics (NASDAQ:RAPP) Sees Strong Trading Volume - Time to Buy...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available